Using the technology acceptance model to assess clinician perceptions and experiences with a rheumatoid arthritis outcomes dashboard: qualitative study
BMC Medical Informatics and Decision Making · 27.05.2024 · 24 (1)
DOI: 10.1186/s12911-024-02530-2 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift BMC Medical Informatics and Decision Making, online erschienen am 27.05.2024. Verfasst von Catherine Nasrallah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Qualitative Research, Electronic Health Records, Attitude of Health Personnel. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, AHRQ HHS.
Abstract (Originalsprache)
Background
Improving shared decision-making using a treat-to-target approach, including the use of clinical outcome measures, is important to providing high quality care for rheumatoid arthritis (RA). We developed an Electronic Health Record (EHR) integrated, patient-facing sidecar dashboard application that displays RA outcomes, medications, and lab results for use during clinical visits (“RA PRO dashboard”). The purpose of this study was to assess clinician perceptions and experiences using the dashboard in a university rheumatology clinic.
Methods
We conducted focus group (FG) discussions with clinicians who had access to the dashboard as part of a randomized, stepped-wedge pragmatic trial. FGs explored clinician perceptions towards the usability, acceptability, and usefulness of the dashboard. FG data were analyzed thematically using deductive and inductive techniques; generated themes were categorized into the domains of the Technology Acceptance Model (TAM).
Results
3 FG discussions were conducted with a total of 13 clinicians. Overall, clinicians were enthusiastic about the dashboard and expressed the usefulness of visualizing RA outcome trajectories in a graphical format for motivating patients, enhancing patient understanding of their RA outcomes, and improving communication about medications. Major themes that emerged from the FG analysis as barriers to using the dashboard included inconsistent collection of RA outcomes leading to sparse data in the dashboard and concerns about explaining RA outcomes, especially to patients with fibromyalgia. Other challenges included time constraints and technical difficulties refreshing the dashboard to display real-time data. Methods for integrating the dashboard into the visit varied: some clinicians used the dashboard at the beginning of the visit as they documented RA outcomes; others used it at the end to justify changes to therapy; and a few shared it only with stable patients.
Conclusions
The study provides valuable insights into clinicians’ perceptions and experiences with the RA PRO dashboard. The dashboard showed promise in enhancing patient-clinician communication, shared decision-making, and overall acceptance among clinicians. Addressing challenges related to data collection, education, and tailoring dashboard use to specific patient populations will be crucial for maximizing its potential impact on RA care. Further research and ongoing improvements in dashboard design and implementation are warranted to ensure its successful integration into routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine, University of California, San Francisco, CA, USA.
- San Francisco Veterans Affairs Medical Center, 4150 Clement Street, #500A, San Francisco, CA, 94121, USA.
- Center for Vulnerable Populations and Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.
- Division of Rheumatology, Department of Medicine, University of California, San Francisco, CA, USA. gabriela.schmajuk@ucsf.edu.
- San Francisco Veterans Affairs Medical Center, 4150 Clement Street, #500A, San Francisco, CA, 94121, USA. gabriela.schmajuk@ucsf.edu.
Förderung
- NIAMS NIH HHS
- AHRQ HHS
Zitieren
APA
Nasrallah, C., Wilson, C., Hamblin, A., Young, C., Jacobsohn, L., Nakamura, M. C., Gross, A., Matloubian, M., Ashouri, J., Yazdany, J., & Schmajuk, G. (2024). Using the technology acceptance model to assess clinician perceptions and experiences with a rheumatoid arthritis outcomes dashboard: qualitative study. BMC Medical Informatics and Decision Making, 24(1). https://doi.org/10.1186/s12911-024-02530-2
Vancouver
Nasrallah C, Wilson C, Hamblin A, Young C, Jacobsohn L, Nakamura MC, et al. Using the technology acceptance model to assess clinician perceptions and experiences with a rheumatoid arthritis outcomes dashboard: qualitative study. BMC Medical Informatics and Decision Making. 2024;24(1). doi:10.1186/s12911-024-02530-2
BibTeX
@article{Nasrallah2024,
author = {Nasrallah, Catherine and Wilson, Cherish and Hamblin, Alicia and Young, Cammie and Jacobsohn, Lindsay and Nakamura, Mary C and Gross, Andrew and Matloubian, Mehrdad and Ashouri, Judith and Yazdany, Jinoos and Schmajuk, Gabriela},
title = {Using the technology acceptance model to assess clinician perceptions and experiences with a rheumatoid arthritis outcomes dashboard: qualitative study},
journal = {BMC Medical Informatics and Decision Making},
year = {2024},
volume = {24},
number = {1},
doi = {10.1186/s12911-024-02530-2}
}
EUVIMED